Intracranial Hematoma Drug Market Growth Outlook Reveals A CAGR Of 9.7% And A Market Value Of $2.79 Billion By 2030
The Intracranial Hematoma Drug market size is expected to reach $2.79 billion by 2030 at a CAGR of 9.7%, driven by rising incidence of traumatic brain injuries.
